{"organizations": [], "uuid": "29aad85848a3b6ae4349a0e351a3b6a395e82f05", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180213.html", "section_title": "Archive News &amp; Video for Tuesday, 13 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-staidson-beijing-biopharmaceutical/brief-staidson-beijing-biopharmaceuticals-unit-to-invest-in-beijing-based-firm-and-limited-partnership-idUSL4N1Q33LR", "country": "US", "domain_rank": 408, "title": "Staidson Beijing BioPharmaceuticals unit to invest in Beijing-based firm and limited partnership", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-13T17:22:00.000+02:00", "replies_count": 0, "uuid": "29aad85848a3b6ae4349a0e351a3b6a395e82f05"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-staidson-beijing-biopharmaceutical/brief-staidson-beijing-biopharmaceuticals-unit-to-invest-in-beijing-based-firm-and-limited-partnership-idUSL4N1Q33LR", "ord_in_thread": 0, "title": "Staidson Beijing BioPharmaceuticals unit to invest in Beijing-based firm and limited partnership", "locations": [], "entities": {"persons": [], "locations": [{"name": "beijing", "sentiment": "none"}], "organizations": [{"name": "staidson beijing biopharmaceuticals", "sentiment": "negative"}, {"name": "reuters) - staidson beijing biopharmaceuticals co ltd", "sentiment": "neutral"}, {"name": "thomson reuters trust principles", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 13(Reuters) - Staidson Beijing BioPharmaceuticals Co Ltd\n* Says coâ€™s Zhejiang-based wholly owned investment unit plans to invest 30 million yuan in Beijing-based medical science and technology development firm (target firm)\n* Says unit will hold 5 percent stake in target firm\n* Says unit plans to invest 35.5 million yuan in a limited partnership for portion worth 7.8 million yuan\nSource text in Chinese: goo.gl/aFWS6W ; goo.gl/ArVSG1\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/ArVSG1", "https://goo.gl/aFWS6W", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-13T17:22:00.000+02:00", "crawled": "2018-02-14T12:25:11.022+02:00", "highlightTitle": ""}